Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Inflammation and Recovery in Gastrectomy
NCT03960775Completed
- Sponsor
- Yonsei University
- Start
- Apr 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in gastric cancer (GC) (2 arms), sponsored by Yonsei University. Primary endpoint: C-reactive protein. Started Apr 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03960775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03960775.